633
Views
2
CrossRef citations to date
0
Altmetric
Invited Reviews

Physiological and metabolic adaptations in pregnancy: importance of trimester-specific reference intervals to investigate maternal health and complications

&
Pages 76-92 | Received 12 Jul 2021, Accepted 07 Sep 2021, Published online: 29 Sep 2021

References

  • Naylor KE, Iqbal P, Fledelius C, et al. The effect of pregnancy on bone density and bone turnover. J Bone Miner Res. 2000;15(1):129–137.
  • Feldt-Rasmussen U, Mathiesen ER. Endocrine disorders in pregnancy: Physiological and hormonal aspects of pregnancy. Best Pract Res Clin Endocrinol Metab. 2011;25(6):875–884.
  • De Jesus GR, Mendoza-Pinto C, De Jesus NR, et al. Understanding and managing pregnancy in patients with lupus. Autoimmune Dis. 2015;2015:943490.
  • Korevaar TIM, Medici M, Visser TJ, et al. Thyroid disease in pregnancy: New insights in diagnosis and clinical management. Nat Rev Endocrinol. 2017;13(10):610–622.
  • Salmeen KE, Block-Kurbisch IJ. Thyroid physiology during pregnancy, postpartum, and lactation. Chapter 4. In: Kovacs C, Deal C, editors. Maternal-fetal and neonatal endocrinology: physiology, pathophysiology, and clinical management. Cambridge MS: Academic Press; 2019. p. 53–60.
  • Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31(5):702–755.
  • Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 1997;18(3):404–433.
  • Yamazaki K, Sato K, Shizume K, et al. Potent thyrotropic activity of human chorionic gonadotropin variants in terms of 125I incorporation and de novo synthesized thyroid hormone release in human thyroid follicles. J Clin Endocrinol Metab. 1995;80(2):473–479.
  • Glinoer D, De Nayer P, Robyn C, et al. Serum levels of intact human chorionic gonadotropin (HCG) and its free a and β subunits, in relation to maternal thyroid stimulation during normal pregnancy. J Endocrinol Invest. 1993;16(11):881–888.
  • Springer D, Jiskra J, Limanova Z, et al. Thyroid in pregnancy: from physiology to screening. Crit Rev Clin Lab Sci. 2017;54(2):102–116.
  • Ain KB, Mori Y, Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metab. 1987;65(4):689–696.
  • McKinnon B, Li H, Richard K, et al. Synthesis of thyroid hormone binding proteins transthyretin and albumin by human trophoblast. J Clin Endocrinol Metab. 2005;90(12):6714–6720.
  • James R, Franklyn JA, Kilby MD. Placental transport of thyroid hormone. Best Pract Res Clin Endocrinol Metab. 2007;21(2):253–264.
  • Yan Y-Q, Dong Z-L, Dong L, et al. Trimester- and method-specific reference intervals for thyroid tests in pregnant chinese women: Methodology, euthyroid definition and iodine status can influence the setting of reference intervals. Clin Endocrinol. 2011;74(2):262–269.
  • Springer D, Zima T, Limanova Z. Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol. 2009;160(5):791–797.
  • Bestwick JP, John R, Maina A, et al. Thyroid stimulating hormone and free thyroxine in pregnancy: Expressing concentrations as multiples of the median (moms). Clin Chim Acta. 2014;430:33–37.
  • Shen FX, Xie ZW, Lu SM, et al. Gestational thyroid reference intervals in antibody-negative Chinese women. Clin Biochem. 2014;47(7–8):673–675.
  • Bocos-Terraz J, Izquierdo-Álvarez S, Bancalero-Flores J, et al. Thyroid hormones according to gestational age in pregnant Spanish women. BMC Res Notes. 2009;2(1):237.
  • La'uluSL, RobertsWL. Ethnic differences in first-trimester thyroid reference intervals. Clin Chem. 2011;57(6):913–915.
  • MännistöT, SurcelH-M, RuokonenA, et al. Early pregnancy reference intervals of thyroid hormone concentrations in a thyroid antibody-negative pregnant population. Thyroid. 2011;21(3):291–298.
  • Stricker R, Echenard M, Eberhart R, et al. Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol. 2007;157(4):509–514.
  • Xing J, Yuan E, Li J, et al. Trimester- and assay-specific thyroid reference intervals for pregnant women in China. Int J Endocrinol. 2016;2016:3754213.
  • Karakosta P, Chatzi L, Bagkeris E, et al. First- and second-trimester reference intervals for thyroid hormones during pregnancy in “rhea” mother-child cohort, Crete, Greece. J Thyroid Res. 2011;2011:490783.
  • Lambert-Messerlian G, McClain M, Haddow JE, FaSTER Research Consortium, et al. First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (first- and second-trimester evaluation of risk for aneuploidy) research consortium study. Am J Obstet Gynecol. 2008;199(1):62.e1–e6.
  • Li C, Shan Z, Mao J, et al. Assessment of thyroid function during first-trimester pregnancy: What is the rational upper limit of serum TSH during the first trimester in chinese pregnant women? J Clin Endocrinol Metab. 2014;99(1):73–79.
  • Medici M, de Rijke YB, Peeters RP, et al. Maternal early pregnancy and newborn thyroid hormone parameters: the generation R study. J Clin Endocrinol Metab. 2012;97(2):646–652.
  • Gilbert RM, Hadlow NC, Walsh JP, et al.Assessment of thyroid function during pregnancy: first-trimester (weeks 9–13) reference intervals derived from Western Australian women. Med J Aust. 2008;190(4):219–253.
  • Wang QW, Yu B, Huang RP, et al. Assessment of thyroid function during pregnancy: the advantage of self-sequential longitudinal reference intervals. aoms. 2011;4:679–684.
  • Haddow JE, Knight GJ, Palomaki GE, et al. The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen. 2004;11(4):170–174.]
  • Bunch DR, Firmender K, Harb R, et al. First- and second-trimester reference intervals for thyroid function testing in a US population. Am J Clin Pathol. 2021;155(6):776–780.
  • MediciM, KorevaarTIM, VisserWE, et al. Thyroid function in pregnancy: what is normal? Clin Chem. 2015;61(5):704–713.
  • Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the american thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315–389.
  • Korevaar TIM, Medici M, De Rijke YB, et al. Ethnic differences in maternal thyroid parameters during pregnancy: the Generation R study. J Clin Endocrinol Metab. 2013;98(9):3678–3686.
  • Yuen LY, Chan MHM, Sahota DS, et al. Development of gestational age-specific thyroid function test reference intervals in four analytic platforms through multilevel modeling. Thyroid. 2020;30(4):598–608.
  • Donovan LE, Metcalfe A, Chin A, et al. A practical approach for the verification and determination of site- and trimester-specific reference intervals for thyroid function tests in pregnancy. Thyroid. 2019;29(3):412–419.
  • Stiphout W, Hofman A, Bruijn AMD. Serum lipids in young women before, during, and after pregnancy. Am J Epidemiol. 1987;126(5):922–928.
  • Barrett HL, Nitert MD, McIntyre HD, et al. Normalizing metabolism in diabetic pregnancy: is it time to target lipids? Diabetes Care. 2014;37(5):1484–1493.
  • Guarino M, Cossiga V, Morisco F. The interpretation of liver function tests in pregnancy. Best Pract Res Clin Gastroenterol. 2020;44–45:101667.
  • Klajnbard A, Szecsi PB, Colov NP, et al. Laboratory reference intervals during pregnancy, delivery and the early postpartum period. Clin Chem Lab Med. 2010;48(2):237–248.
  • Friis Petersen J, Friis-Hansen LJ, Jensen AK, et al. Early pregnancy reference intervals; 29 serum analytes from 4 to 12 weeks’ gestation in naturally conceived and uncomplicated pregnancies resulting in live births. Clin Chem Lab Med. 2019;57(12):1956–1967.
  • Odhiambo C, Omolo P, Oyaro B, et al. Establishment of reference intervals during normal pregnancy through six months postpartum in Western Kenya. PLOS One. 2017;12(4):e0175546.
  • Bacq Y, Zarka O, Brechot J, et al. Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology. 1996;23(5):1030–1034.
  • Jin Y, Lu J, Jin H, et al. Reference intervals for biochemical, haemostatic and haematological parameters in healthy Chinese women during early and late pregnancy. Clin Chem Lab Med. 2018;56(6):973–979.
  • Dai Y, Liu J, Yuan E, et al. Gestational age-specific reference intervals for 15 biochemical measurands during normal pregnancy in China. Ann Clin Biochem. 2018;55(4):446–452.
  • Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114(6):1326–1331.
  • Cattozzo G, Calonaci A, Albeni C, et al. Reference values for alanine aminotransferase, α-amylase, aspartate aminotransferase, γ-glutamyltransferase and lactate dehydrogenase measured according to the IFCC standardization during uncomplicated pregnancy. Clin Chem Lab Med. 2013;51(10):e239–e241.
  • Girling JC, Dow E, Smith JH. Liver function tests in pre-eclampsia: Importance of comparison with a reference range derived for normal pregnancy. BJOG. 1997;104(2):246–250.
  • Larsson A, Palm M, Hansson LO, et al. Reference values for clinical chemistry tests during normal pregnancy. BJOG. 2008;115(7):874–881.
  • David AL, Kotecha M, Girling JC. Factors influencing postnatal liver function tests. BJOG
  • Teasdale S, Morton A. Changes in biochemical tests in pregnancy and their clinical significance. Obstet Med. 2018;11(4):160–170.
  • Okesina AB, Donaldson D, Lascelles PT, et al. Effect of gestational age on levels of serum alkaline phosphatase isoenzymes in healthy pregnant women. Int J Gynecol Obstet. 1995;48(1):25–29.
  • Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64(4):933–945.
  • Combes B, Shore GM, Cunningham FG, et al. Serum γ-glutamyl transpeptidase activity in viral hepatitis: Suppression in pregnancy and by birth control pills. Gastroenterology. 1977;72(2):271–274.
  • Gohel GG. Evaluation of changes in liver function test in first, second and third trimester of normal pregnancy. Int J Reprod Contracept Obs Gynecol. 2013;2:1789–2320.
  • Larsson A, Palm M, Hansson L-O, et al. Reference values for alpha1-acid glycoprotein, alpha1-antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and IgM during pregnancy. Acta Obstet Gynecol Scand. 2008;87(10):1084–1088.
  • Berstien I. Plasma volume expansion in early pregnancy. Obstet Gynecol. 2001;97:669–672.
  • Martin JN, Brewer JM, Wallace K, et al. Hellp syndrome and composite major maternal morbidity: importance of Mississippi classification system. J Matern Neonatal Med. 2013;26(12):1201–1206.
  • Emet T, Üstüner I, Güven SG, et al. Plasma lipids and lipoproteins during pregnancy and related pregnancy outcomes. Arch Gynecol Obstet. 2013;288(1):49–55.
  • Wang C, Kong L, Yang Y, et al. Recommended reference values for serum lipids during early and Middle pregnancy: a retrospective study from China. Lipids Health Dis. 2018;17(1):246.
  • Jo YS, Cheon JY, Ahn JW, et al. Pentraxin 3 and lipid profile status in pregnancy. J Obstet Gynaecol. 2017;37(6):727–730.
  • Dathan-Stumpf A, Vogel M, Jank A, et al. Reference intervals of serum lipids in the second and third trimesters of pregnancy in a caucasian cohort: the LIFE child study. Arch Gynecol Obstet. 2019;300(6):1531–1539.
  • Mankuta D, Elami-Suzin M, Elhayani A, et al. Lipid profile in consecutive pregnancies. Lipids Health Dis. 2010;9(1):58.
  • ChiangAN, YangML, HungJH, et al. Alterations of serum lipid levels and their biological relevances during and after pregnancy. Life Sci. 1995;56(26):2367–2375.
  • Wang J, Li Z, Lin L. Maternal lipid profiles in women with and without gestational diabetes mellitus. Medicine. 2019;98(16):e15320.
  • Zheng W, Huang W, Zhang L, et al. Changes in serum lipid levels during pregnancy and association with neonatal outcomes: a large cohort study. Reprod Sci. 2018;25(9):1406–1412.
  • Tranquilli AL, Cester N, Giannubilo SR, et al. Plasma lipids and physicochemical properties of the erythrocyte plasma membrane throughout pregnancy. Acta Obstet Gynecol Scand. 2004;83(5):443–448.
  • Piechota W, Staszewski A. Reference ranges of lipids and apolipoproteins in pregnancy. Eur J Obstet Gynecol Reprod Biol. 1992;45(1):27–35.
  • Lippi G, Albiero A, Montagnana M, et al. Lipid and lipoprotein profile in physiological pregnancy. Clin Lab. 2007;53(3–4):173–177.
  • Shen H, Liu X, Chen Y, et al. Associations of lipid levels during gestation with hypertensive disorders of pregnancy and gestational diabetes mellitus: a prospective longitudinal cohort study. BMJ Open. 2016;6(12):e013509.
  • Herrera E, Lasunción MA, Gomez-Coronado D, et al. Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Am J Obstet Gynecol. 1988;158(6 Pt 2):1575–1583.
  • Di Cianni G, Miccoli R, Volpe L, et al. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med. 2005;22(1):21–25.
  • Hao ZM, Ye YF, Zhang YK, et al. Lipoprotein lipase and lipid profiles in plasma and placenta from normal pregnancies compared with patients with intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2016;203:279–285.
  • Ryckman KK, Spracklen CN, Smith CJ, et al. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG. 2015;122(5):643–651.
  • Barrett HL, Nitert MD, McIntyre HD, et al. Maternal lipids in pre-eclampsia: innocent bystander or culprit? Hypertens Pregnancy. 2014;33(4):508–523.
  • Carter J. Serum bile acids in normal pregnancy. BJOG. 1991;98(6):540–543.
  • Zhu B, Yin P, Ma Z, et al. Characteristics of bile acids metabolism profile in the second and third trimesters of normal pregnancy. Metabolism. 2019;95:77–83.
  • Reyes H. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. Hepatology. 2008;47(2):376–379.
  • Gavin IIJ, Alberti KG, Davidson MD, Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl 1):S5–S20.
  • Yang Y, Jiang H, Tang A, et al. Changes of serum homocysteine levels during pregnancy and the establishment of reference intervals in pregnant chinese women. Clin Chim Acta. 2019;489:1–4.
  • Zhang Z, Yuan E, Liu J, et al. Gestational age-specific reference intervals for blood copper, zinc, calcium, magnesium, iron, lead, and cadmium during normal pregnancy. Clin Biochem. 2013;46(9):777–780.
  • Tsuprykov O, Buse C, Skoblo R, et al. Reference intervals for measured and calculated free 25-hydroxyvitamin D in normal pregnancy. J Steroid Biochem Mol Biol. 2018;181:80–87.
  • Schroder TH, Tan A, Mattman A, et al. Reference intervals for serum total vitamin B12 and holotranscobalamin concentrations and their change points with methylmalonic acid concentration to assess vitamin B12 status during early and mid-pregnancy. Clin Chem Lab Med. 2019;57(11):1790–1798.
  • Cheung KL, Lafayette RA. Renal physiology of pregnancy. Adv Chronic Kidney Dis. 2013;20(3):209–214.
  • Wiles KS, Nelson-Piercy C, Bramham K. Reproductive health and pregnancy in women with chronic kidney disease. Nat Rev Nephrol. 2018;14(3):165–184.
  • Rasmussen PE, Nielsen FR. Hydronephrosis during pregnancy: a literature survey. Eur J Obstet Gynecol Reprod Biol. 1988;27(3):249–259.
  • Wiles K, Bramham K, Seed PT, et al. Serum creatinine in pregnancy: a systematic review. Kidney Int Rep. 2019;4(3):408–419.
  • Maynard SE, Thadhani R. Pregnancy and the kidney. J Am Soc Nephrol. 2009;20(1):14–22.
  • Lund C, Donovan J. Blood volume during pregnancy. Significance of plasma and red cell volumes. Am J Obs Gynecol. 1967;98(3):394–403.
  • Taylor DJ, Lind T. Red cell mass during and after normal pregnancy. Br J Obstet Gynaecol. 1979;86(5):364–370.
  • Milman N, Bergholt T, Byg K-E, et al. Reference intervals for haematological variables during normal pregnancy and postpartum in 434 healthy Danish women. Eur J Haematol. 2007;79(1):39–46.
  • Li A, Yang S, Zhang J, et al. Establishment of reference intervals for complete blood count parameters during normal pregnancy in beijing. J Clin Lab Anal. 2017;31(6):e22150.
  • Bakrim S, Motiaa Y, Ouarour A, et al. Hematological parameters of the blood count in a healthy population of pregnant women in the northwest of Morocco (Tetouan-M’diq-Fnideq provinces). Pan Afr Med J. 2018;29:205.
  • Shen C, Jiang Y-M, Shi H, et al. A prospective, sequential and longitudinal study of haematological profile during normal pregnancy in Chinese women. J Obstet Gynaecol. 2010;30(4):357–361.
  • Akinbami AA, Ajibola SO, Rabiu KA, et al. Hematological profile of normal pregnant women in Lagos, Nigeria. Int J Womens Health. 2013;5:227–232.
  • Akingbola TS, Adewole IF, Adesina OA, et al. Haematological profile of healthy pregnant women in ibadan, South-Western Nigeria. J Obstet Gynaecol (Lahore). 2006;26(8):763–769.
  • Balloch AJ, Cauchi MN. Reference ranges for haematology parameters in pregnancy derived from patient populations. Clin Lab Haematol. 1993;15(1):7–14.
  • American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 95: Anemia in pregnancy. Obstet Gynecol. 2008;112(1):201–207.
  • Milman N. Iron in pregnancy - How do we secure an appropriate iron status in the mother and child?Ann Nutr Metab. 2011;59(1):50–54.
  • World Health Organization. Prevalence of anaemia in women aged 15–49, by pregnancy status (%) [Internet]. [cited 2021 Feb 12]. Available from: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4552
  • Daru J, Allotey J, Peña-Rosas JP, et al. Serum ferritin thresholds for the diagnosis of iron deficiency in pregnancy: a systematic review. Transfusion Med. 2017;27(3):167–174.
  • Sanci M, Töz E, Ince O, et al. Reference values for maternal total and differential leukocyte counts in different trimesters of pregnancy and the initial postpartum period in Western Turkey. J Obstet Gynaecol. 2017;37(5):571–575.
  • Kühnert M, Schmidt S. Changes in lymphocyte subsets during pregnancy and post-partum in cases of beginning eclampsia. J Perinat Med. 2000;28:389–398.
  • Hershko Klement A, Hadi E, Asali A, et al. Neutrophils to lymphocytes ratio and platelets to lymphocytes ratio in pregnancy: a population study. Magalhaes M, editor. PLOS One. 2018;13(5):e0196706.
  • Lurie S, Weiner E, Golan A, et al. Total and differential leukocyte count percentiles in healthy singleton term women during the first stage of labor. Gynecol Obstet Invest. 2014;78(4):251–254.
  • Sivasankar R, Kumar RA, Baraz R, et al. The white cell count in pregnancy and labour: a reference range. J Matern Neonatal Med. 2015;28(7):790–792.
  • Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol. 2017;17(8):469–482.
  • Sargent IL, Borzychowski AM, Redman CWG. NK cells and human pregnancy-an inflammatory view. Trends Immunol. 2006;27(9):399–404.
  • Laskarin G, Kämmerer U, Rukavina D, et al. Antigen-presenting cells and materno-fetal tolerance: an emerging role for dendritic cells. Am J Reprod Immunol. 2007;58(3):255–267.
  • Collins MK, Tay CS, Erlebacher A. Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J Clin Invest. 2009;119(7):2062–2073.
  • Reese JA, Peck JD, Deschamps DR, et al. Platelet counts during pregnancy. N Engl J Med. 2018;379(1):32–43.
  • Imafuku Y, Tanaka K, Takahashi K, et al. Identification of a dysfibrinogenemia of gammaR275C (fibrinogen Fukushima). Clin Chim Acta. 2002;325(1–2):151–156.
  • Cui C, Yang S, Zhang J, et al. Trimester-specific coagulation and anticoagulation reference intervals for healthy pregnancy. Thromb Res. 2017;156:82–86.
  • Wang M, Lu S, Li S, et al. Reference intervals of D-dimer during the pregnancy and puerperium period on the STA-R evolution coagulation analyzer. Clin Chim Acta. 2013;425:176–180.
  • Gutiérrez García I, Pérez Cañadas P, Martínez Uriarte J, et al. D-dimer during pregnancy: establishing trimester-specific reference intervals. Scand J Clin Lab Invest. 2018;78(6):439–442.
  • Wickström K, Edelstam G, Löwbeer C, et al. Reference intervals for plasma levels of fibronectin, von willebrand factor, free protein S and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest. 2004;64(1):31–40.
  • Liu JJ, Yuan EW, Lee L. Gestational age-specific reference intervals for routine haemostatic assays during normal pregnancy. Clin Chim Acta. 2012;413(1–2):258–261.
  • Szecsi PB, Jørgensen M, Klajnbard A, et al. Haemostatic reference intervals in pregnancy. Thromb Haemost. 2010;103(4):718–727.
  • Gong JM, Shen Y, He YX. Reference intervals of routine coagulation assays during the pregnancy and puerperium period. J Clin Lab Anal. 2016;30:912–917.
  • Genc MR, Ford CE. The clinical use of inflammatory markers during pregnancy. Curr Opin Obstet Gynecol. 2010;22(2):116–121.
  • Azizia MM, Irvine LM, Coker M, et al. The role of C-reactive protein in modern obstetric and gynecological practice. Acta Obstet Gynecol Scand. 2006;85(4):394–401.
  • Belo L, Santos-Silva A, Rocha S, et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol. 2005;123(1):46–51.
  • Kristensen K, Wide-Swensson D, Lindström V, et al. Serum amyloid a protein and C-reactive protein in normal pregnancy and preeclampsia. Gynecol Obstet Invest. 2009;67(4):275–280.
  • von Versen-Hoeynck FM, Hubel CA, Gallaher MJ, et al. Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia. Am J Hypertens. 2009;22(6):687–692.
  • Watts DH, Krohn MA, Wener MH, et al. C-reactive protein in normal pregnancy. Obstet Gynecol. 1991;77(2):176–180.
  • Ferguson KK, McElrath TF, Chen Y-H, et al. Longitudinal profiling of inflammatory cytokines and C-reactive protein during uncomplicated and preterm pregnancy. Am J Reprod Immunol. 2014;72(3):326–336.
  • Hwang HS, Kwon JY, Kim MA, et al. Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet. 2007;98(2):105–109.
  • Raio L, Bersinger NA, Malek A, et al. Ultra-high sensitive C-reactive protein during normal pregnancy and in preeclampsia: a pilot study. J Hypertens. 2019;37(5):1012–1017.
  • Christian LM, Porter K. Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index. Cytokine. 2014;70(2):134–140.
  • Stewart FM, Freeman DJ, Ramsay JE, et al. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab. 2007;92(3):969–975.
  • Sacks GP, Seyani L, Lavery S, et al. Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod. 2004;19(4):1025–1030.
  • Li K. Predictive value of procalcitonin or c-reactive protein for subclinical intrauterine infection in patients with premature rupture of membranes (PROM). JPM. 2016;10(3/4):23.
  • Areia AL, Areia M, Mota-Pinto A. Procalcitonin in preterm rupture of membranes: a systematic review and Meta-analysis. Arch Gynecol Obstet. 2021;303(4):917–924.
  • Dulay AT, Buhimschi IA, Zhao G, et al. Compartmentalization of acute phase reactants interleukin-6, C-reactive protein and procalcitonin as biomarkers of intra-amniotic infection and chorioamnionitis. Cytokine. 2015;76(2):236–243.
  • Hu Y, Yang M, Zhou Y, et al. Establishment of reference intervals for procalcitonin in healthy pregnant women of chinese population. Clin Biochem. 2017;50(3):150–154.
  • Paccolat C, Harbarth S, Courvoisier D, et al. Procalcitonin levels during pregnancy, delivery and postpartum. J Perinat Med. 2011;39(6):679–683.
  • Morgenthaler NG, Struck J, Fischer-Schulz C, et al. Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA. Clin Lab. 2002;48:263–270.
  • Assumma M, Signore F, Pacifico L, et al. Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: a longitudinal study. Clin Chem. 2000;46(10):1583–1587.
  • Ma Y, Shao M, Shao X, et al. Establishment of reference intervals for maternal blood and umbilical cord blood procalcitonin in healthy Chinese women in late pregnancy. J Obstet Gynaecol Res. 2019;45(11):2178–2184.
  • Stokkeland LMT, Giskeødegård GF, Stridsklev S, et al. Serum cytokine patterns in first half of pregnancy. Cytokine. 2019;119:188–196.
  • Szarka A, Rigó J, Lázár L, et al. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010;11:59.
  • Fu Y, Tang L, Hu M, et al. Changes of serum interleukin-6 in healthy pregnant women and establishment of relevant reference intervals. Clin Chim Acta. 2020;502:116–119.
  • Ku DHW, Arkel YS, Paidas MP, et al. Circulating levels of inflammatory cytokines(IL-1 beta and TNF-alpha), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies. Thromb Haemost. 2003;90(6):1074–1079.
  • Velez DR, Fortunato SJ, Morgan N, et al. Patterns of cytokine profiles differ with pregnancy outcome and ethnicity. Hum Reprod. 2008;23(8):1902–1909.
  • Meah VL, Cockcroft JR, Backx K, et al. Cardiac output and related haemodynamics during pregnancy: a series of Meta-analyses. Heart. 2016;102(7):518–526.
  • Joyal D, Leya F, Koh M, et al. Troponin I levels in patients with preeclampsia. Am J Med. 2007;120(9):819.e13–819.e14.
  • Kimura Y, Kato T, Miyata H, et al. Factors associated with increased levels of brain natriuretic peptide and cardiac troponin I during the peripartum period. PLOS One. 2019;14(2):e0211982.
  • ShivversSA, WiansFH, KefferJH, et al. Maternal cardiac troponin I levels during normal labor and delivery. Am J Obstet Gynecol. 1999;180(1 Pt 1):122–127.
  • Ravichandran J, Woon SY, Quek YS, et al. High-sensitivity cardiac troponin I levels in normal and hypertensive pregnancy. Am J Med. 2019;132(3):362–366.
  • Furenäs E, Eriksson P, Wennerholm UB, et al. Pregnancy in a healthy population: dynamics of NTproBNP and hs-cTroponin T. Open Hear. 2020;7:1293.
  • Hameed AB, Chan K, Ghamsary M, et al. Longitudinal changes in the B-type natriuretic peptide levels in normal pregnancy and postpartum. Clin Cardiol. 2009;32(8):E60–E62.
  • Mayama M, Yoshihara M, Uno K, et al. Factors influencing brain natriuretic peptide levels in healthy pregnant women. Int J Cardiol. 2017;228:749–753.
  • Burlingame JM, Yamasato K, Ahn HJ, et al. B-type natriuretic peptide and echocardiography reflect volume changes during pregnancy. J Perinat Med. 2017;45:577–583.
  • Resnik JL, Hong C, Resnik R, et al. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol. 2005;193(2):450–454.
  • Yurteri-Kaplan L, Saber S, Zamudio S, et al. Brain natriuretic peptide in term pregnancy. Reprod Sci. 2012;19(5):520–525.
  • EzekowitzJA, O'MearaE, McDonaldMA, et al. 2017 Comprehensive update of the Canadian cardiovascular society guidelines for the management of heartfailure. Can J Cardiol. 2017;33(11):1342–1433.
  • Phumsiripaiboon P, Suksai M, Suntharasaj T, et al. Screening for pre-eclampsia: performance of national institute for health and care excellence guidelines versus American College of Obstetricians and Gynecologists recommendations. J Obstet Gynaecol Res. 2020;46(11):2323–2331.
  • Hertig A, Berkane N, Lefevre G, et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem. 2004;50(9):1702–1703.
  • Hertig A, Liere P. New markers in preeclampsia. Clin Chim Acta. 2010;411(21–22):1591–1595.
  • Jadli A, Sharma N, Damania K, et al. Promising prognostic markers of preeclampsia: new avenues in waiting. Thromb Res. 2015;136(2):189–195.
  • Ura B, Feriotto G, Monasta L, et al. Potential role of circulating microRNAs as early markers of preeclampsia. Taiwan J Obstet Gynecol. 2014;53(2):232–234.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.